Viewing Study NCT02636595


Ignite Creation Date: 2025-12-24 @ 1:53 PM
Ignite Modification Date: 2026-02-20 @ 11:18 PM
Study NCT ID: NCT02636595
Status: COMPLETED
Last Update Posted: 2021-07-13
First Post: 2015-12-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: The Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4)
Sponsor: AbbVie
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-11
Start Date Type: ACTUAL
Primary Completion Date: 2016-10
Primary Completion Date Type: ACTUAL
Completion Date: 2017-01
Completion Date Type: ACTUAL
First Submit Date: 2015-12-16
First Submit QC Date: None
Study First Post Date: 2015-12-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2017-08-17
Results First Submit QC Date: None
Results First Post Date: 2017-09-14
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2017-02-01
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2021-07-09
Last Update Post Date: 2021-07-13
Last Update Post Date Type: ACTUAL